Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gratitude journaling tested as a pain relief tool for jaw disorders

NCT ID NCT06977100

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This study tests whether a 2-week gratitude journaling activity is feasible and acceptable for people with temporomandibular disorder (TMD) and other chronic pain conditions. Sixty participants will either write down things they are grateful for or reflect on daily activities. Researchers will measure how many complete the program and how satisfied they are, and also explore whether pain and its impact on daily life improve.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
gratitude journaling
What this could lead to
If it works, this could point toward a simple, low-cost way to help manage jaw pain and related chronic pain conditions.
What could go wrong
This is a very small, early feasibility study with only 60 participants. It is not designed to prove that journaling reduces pain, only that people will try it and like it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * participants between the ages of 18 and 80 * pain in the temporomandibular (TMD) region (jaw and/or temple area) * duration of pain is at least 3 months * average pain score ≥4 on a 0-10 numerical rating scale over the past week * have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis. * able to read, understand, and write in English. Exclusion Criteria: * history of TMD surgery * neoplasm or injury/trauma to the TMD area * cancer-related pain * scheduled for any surgeries during the study time-frame * current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes * pregnant or lactating * severe motor impairments (e.g., muscular dystrophy) * severe psychiatric conditions (e.g., uncontrolled mood disorders) * severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease) * any other conditions that in the opinion of study investigators could make participation in the study unsafe * use of opioids within 48 hours prior to laboratory visit

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Temporomandibular disorders (TMD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.